Skip to main content
Premium Trial:

Request an Annual Quote

Maurizio Grimaldi Joins SRI to Lead Drug Discovery; Loralyn Mears Goes to Gene Logic from Sun Microsystems; Francis Collins and Patrick Brown Win ASHG Awards; and Others

Maurizio Grimaldi has joined Southern Research Institute to lead its drug-discovery team in efforts to develop new drugs for neurological and CNS disorders, SRI said last month. Prior to joining SRI, Grimaldi conducted research at the National Institute for Neurological Disorders and Stroke, the National Institute for Child and Human Development, and the National Institute for Mental Health. From 2000 to 2004, he was an assistant professor of neurology for the Universityof Health Sciences in Bethesda, Md.Grimaldi holds a medical degree as well as a PhD in neuropsychopharmacology and toxicology from the Universityof Napoli, Italy.

Loralyn Mears has joined Gene Logic as vice president for genomics alliances, the company said last week. She comes to Gene Logic from Sun Microsystems, where she established and led the life sciences program. Mears has a PhD in molecular biology.

Jenne Britell has been elected to the board of directors of Quest Diagnostics, bringing the number of board members to 11, the company said on Monday. She is chairman and CEO of Structured Ventures, a consultancy.

Brian Haab has joined the scientific advisory board of GenTel BioSurfaces, the Madison, Wis.-based company said last week. Haab, a special program investigator at Van Andel Research Institute, has been developing protein microarray technologies. He holds a PhD in chemistry from the University of California at Berkeley.

Richard Flavell has joined the scientific advisory board of Seattle Genetics, the Bothell, Wash.-based company said last week. He is chairman and professor of immunobiology at the Yale University School of Medicine and a Howard Hughes investigator. Prior to that, he was chief scientific officer of Biogen an has been a scientific advisor to other companies, including Celltech and CuraGen. Flavell holds a PhD in biochemistry from the Universityof Hull in the UK.

Robert Bohannon has founded his own diagnostics development lab, Environostics, in Durham, NC, GenomeWeb News has learned. Prior to that, he was vice president of technology, R&D at MedTox Diagnostics in Burlington, NC. Bohannon holds a PhD in molecular virology from Baylor College of Medicine and a BA in molecular, cellular, and developmental biology from the University of Colorado at Boulder.

Former New Jerseysenator Bill Bradley has joined the board of directors of microfluidics firm LabNow, the Austin, Texas-based company said on Monday. He is currently a managing director of Allen & Company. Bradley represented New Jerseyin the US Senate from 1979 until1997 and was a professional basketball player with the New York Knicks from 1967 until 1977. He holds a BA in American History from PrincetonUniversity and an MA from the Universityof Oxford.

Francis Collins and Patrick Brown have won awards from the American Society of Human Genetics, ASHG said last week. They will receive the awards during the society's annual meeting in Salt Lake Cityin October.


Collins, director of the National Human Genome Research Institute, will receive the Allan Award medal and a $10,000 check for his lifetime contributions to understanding human genetics and medical implications of human genetics research.


Brown, a Howard Hughes investigator and Stanford University Medical School professor of genetics, will receive the Curt Stern award and a $2,500 check for his work using gene expression microarrays to provide fundamental insights into the genetic mechanisms of cancer and other human disorders, and into the regulation of gene expression.

Dirk Bumann and Mattias Kassack are this year's winners of small grant awards from the Society for Biomolecular Screening, SBS said recently.


Bumann, a group leader at the Hannover Medical School in Germany, is studying Salmonella host-pathogen interactions using a FACS-based high-information content assay that simultaneously monitors several metabolic pathways in live Salmonella. Bumann holds a PhD from the Max Planck Institute of Biochemistry.


Kassack estimates functional and binding properties of compounds at G-protein coupled receptors by flow cytometry. He is currently a lecturer and principal investigator at the University of Bonn Pharmaceutical Institute in Germany. Kassack holds a PhD from the Universityof Bonn.

Promoted? Changing jobs? GenomeWeb News wants to know. E-mail us at [email protected] to announce your move in PEOPLE, a weekly roundup of personnel changes in the genomics industry.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.